(
out of
45
reviews
)
Schedule an Appointment with U of U Health (MyChart)
If you're an existing patient of this provider, please use your U of U Health (MyChart) account to schedule your appointment.
Sign in to U of U Health (MyChart)Haven't set up a U of U Health (MyChart) account yet? Create an account
Need Assistance?
If you're having trouble signing in, need guidance on using U of U Health (MyChart), or require support with your account, please visit our FAQ page.
Clinical Locations
Primary Location
South Jordan Health Center
5126 West Daybreak Parkway
South Jordan
,
UT
84009
University of Utah Hospital
Gastroenterology Endoscopy Center
50 N Medical Dr
Salt Lake City
,
UT
84132
Board Certification
|
American Board of Internal Medicine
|
Patient Rating
Patients consistently describe Dr. Valentine as knowledgeable and highly skilled, noting thorough evaluations and clear treatment plans. Many highlight his attentive listening, clear explanations of conditions and options, and willingness to collaborate with patients and other specialists. Commenters also emphasize his compassion and professionalism, saying he inspires confidence and is easy to recommend.
Generated via Patient Reviews
4.9
/5
( out of
45 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Professor |
|---|---|
| Academic Divisions |
Gastroenterology
|
| Board Certification |
American Board of Internal Medicine
|
Education history
| Undergraduate | Microbiology - University of Texas at Arlington | B.S. |
|---|---|---|
| Professional Medical | Medicine - University of Texas Medical School at Houston | M.D. |
| Internship/Residency | Internal Medicine - Medical College of Virginia | Intern/Resident |
| Fellowship | Gastroenterology - University of Florida College of Medicine | Fellow |
Selected Publications
Journal Article
- Peterson LK, Nandakumar V, Valentine JF, Delgado JC, Saadalla A (2025). The Utility of the Immunoglobulin A Flag Used in Celiac Disease Serology Testing on a Particle-Based Multianalyte Technology Platform. Clinical chemistry, 71(7), 818-820.
- Mellema RA, Queisser KA, Ajanel A, Albtoush N, Smith L, Rondina M, Will J, Valentine JF, Petrey A (2025). Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease. Blood, 146(24), 2979-2992.
- Tsai HY, Chen MH, Yun J, Lai LA, Valentine JF, Bronner MP, Brentnall TA, Pan S, Chen (2025). Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer. Cancer letters, 632, 217977.
- Melmed GY, Oliver B, Kennedy A, Hou JK, Lum D, Singh S, van Deen WK, Oberai R, Weaver SA, Testaverde J, Siegel CA, IBD Qoru (2025). Long-Term Sustained Improvement in Unplanned Healthcare Utilization in Patients With Inflammatory Bowel Disease. The American journal of gastroenterology, 120(11), 2714-2718.
- Chulkina M, Rohmer C, McAninch S, Panganiban RP, Villéger R, Portolese A, Ciocirlan J, Yang W, Cohen C, Koltun W, Valentine JF, Cong Y, Yochum G, Beswick EJ, Pinchuk I (2024). Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease. Journal of Crohn's & colitis, 18(7), 1147-1161.
- Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht A, Brensinger CM, Wu GD, Bittinger K, DINE-CD and SPARC IBD Investigators, Kaur M, Dassopoulos T, Snapper SB, Korzenik JR, Bohm M, Raffals L, Beniwal-Patel P, Hudesman D, Russ K, Brook L, Pekow J, Cross R, Wong U, Bishu S, Bewtra M, Lewis JD, Duerr R, Saha S, Caldera F, Scoville E, Deepak P, Ciorba (2024). Surgery for Crohn's Disease Is Associated with a Dysbiotic Microbiome and Metabolome: Results from Two Prospective Cohorts. Cellular and molecular gastroenterology and hepatology, 18(3), 101357.
- Colombel JF, Ungaro RC, Sands BE, Siegel CA, Wolf DC, Valentine JF, Feagan BG, Neustifter B, Kadali H, Nazarey P, James A, Jairath V, Qasim Khan R (2024). Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER). Clinical gastroenterology and hepatology, 22(7), 1487-1496.e12.
- Lee YJ, Li D, Mujukian A, Debbas P, Hampton M, Mengesha E, Cheng S, Ebinger JE, Chiorean M, Lum D, Damas OM, Braun J, McGovern DPB, Melmed GY, CORALE-IBD Study Grou (2024). Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases, 30(8), 1430-1434.
- Chulkina M, Rohmer C, McAninch S, Panganiban RP, Villéger R, Portolese A, Ciocirlan J, Yang W, Cohen C, Koltun W, Valentine JF, Cong Y, Yochum G, Beswick EJ, Pinchuk I (2024). Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn's Disease. Journal of Crohn's & colitis, 18(7), 1147-1161.
- Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat (2024). TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response.
- Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht AL, Brensinger CM, Wu GD, Bittinger K, DINE-CD, SPARC IBD Investigator (2024). Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts. Cellular and molecular gastroenterology and hepatology, 18(3), 101357.
- Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat (2024). TNF Promoter Hypomethylation Is Associated With Mucosal Inflammation in IBD and Anti-TNF Response. Gastro hep advances, 3(7), 888-898.
- Danese S, Rothenberg ME, Lim JJ, Ding HT, McBride JM, Chen Y, Dash A, Mar JS, Keir M, Peyrin-Biroulet L, Panes J, Colombel JF, Feagan B, Valentine JF, Schreiber (2024). A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis. Clinical gastroenterology and hepatology,
- Mohan BP, Fatima N, Khan SR, Kassab L, Chandan S, Asokkumar R, Valentine JF, Navaneethan U, Kochhar GS, Ma C, Jairath V, Singh (2023). Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. PMID: 37207296 DOI: 10.14309/ajg.0000000000002328. The American journal of gastroenterology,
- Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang J (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endoscopy international open, 11(7), E653-E659.
- Colombel JF, Ungaro RC, Sands BE, Siegel CA, Wolf DC, Valentine JF, Feagan BG, Neustifter B, Kadali H, Nazarey P, James A, Jairath V, Qasim Khan R (2023). Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER). Clinical gastroenterology and hepatology, 22(7), 1487-1496.e12.
- Papamichael K, Jairath V, Zou G, Cohen B, Ritter T, Sands B, Siegel C, Valentine J, Smith M, Vande Casteele N, Dubinsky M, Cheifetz (2022). Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial). BMJ open, 12(4), e057656.
- Tse CS, Van Citters AD, Ricci B, Freundlich NZ, Lee M, Shah SA, Melmed GY, Siegel CA, van Deen WK, IBD Qorus (2022). Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease. Journal of Crohn's & colitis, 16(3), 379-388.
- Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ, HICKORY Study Group (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. The lancet. Gastroenterology & hepatology, 7(2), 128-140.
- Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG, LAUREL Study Group (2022). Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. The lancet. Gastroenterology & hepatology, 7(1), 28-37.
- Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J, HIBISCUS Study Group (2022). Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. The lancet. Gastroenterology & hepatology, 7(1), 17-27.
- Tsai HY, Bronner MP, March JK, Valentine JF, Shroyer NF, Lai LA, Brentnall TA, Pan S, Chen (2022). Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer. Cancer letters, 549, 215915.
- Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, Daperno M, Valentine JF, Laharie D, Baía C, Atreya R, Panaccione R, Rydzewska G, Aguilar H, Vermeire S, BERGAMOT Study Group (2022). Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial. The lancet. Gastroenterology & hepatology,
- Lebish EJ, Morgan NJ, Valentine JF, Beswick E (2022). MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity. Pharmaceuticals (Basel, Switzerland), 15(12),
- Somineni HK, Nagpal S, Venkateswaran S, Cutler DJ, Okou DT, Haritunians T, Simpson CL, Begum F, Datta LW, Quiros AJ, Seminerio J, Mengesha E, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Iskandar H, Dryden GW, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kuemmerle JF, Lazarev M, Li E, Mannon P, Moulton DE, Newberry RD, Patel AS, Pekow J, Saeed SA, Valentine JF, Wang MH, McCauley JL, Abreu MT, Jester T, Molle-Rios Z, Palle S, Scherl EJ, Kwon J, Rioux JD, Duerr RH, Silverberg MS, Zwick ME, Stevens C, Daly MJ, Cho JH, Gibson G, McGovern DPB, Brant SR, Kugathasan (2021). Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. American journal of human genetics, 108(3), 431-445.
- Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson J, Suskind D, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen B, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H, DINE-CD Study Group (2021). A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults with Crohn's Disease. Gastroenterology, 161, 837-852.e9.
- Ost KS, O'Meara TR, Stephens WZ, Chiaro T, Zhou H, Penman J, Bell R, Catanzaro JR, Song D, Singh S, Call DH, Hwang-Wong E, Hanson KE, Valentine JF, Christensen KA, O'Connell RM, Cormack B, Ibrahim AS, Palm NW, Noble SM, Round J (2021). Adaptive immunity induces mutualism between commensal eukaryotes. Nature, 596(7870), 114-118.
- Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Burt RW, Curtin K, Smith K (2019). Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clinical gastroenterology and hepatology, 17(9), 1807-1813.e1.
- Gogokhia L, Buhrke K, Bell R, Hoffman B, Brown DG, Hanke-Gogokhia C, Ajami NJ, Wong MC, Ghazaryan A, Valentine JF, Porter N, Martens E, O'Connell R, Jacob V, Scherl E, Crawford C, Stephens WZ, Casjens SR, Longman RS, Round J (2019). Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell host & microbe, 25(2), 285-299.e8.
- Herfarth H, Barnes EL, Valentine JF, Hanson J, Higgins PDR, Isaacs KL, Jackson S, Osterman MT, Anton K, Ivanova A, Long MD, Martin C, Sandler RS, Abraham B, Cross RK, Dryden G, Fischer M, Harlan W, Levy C, McCabe R, Polyak S, Saha S, Williams E, Yajnik V, Serrano J, Sands BE, Lewis JD, Clinical Research Alliance of the Crohn's and Colitis Foundation (2018). Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology, 155(4), 1098-1108.e9.
- Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson (2018). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflammatory bowel diseases, 24(7), 1539-1546.
- Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE, Newberry RD, Osuntokun BO, Patel AS, Saeed SA, Targan SR, Valentine JF, Wang MH, Zonca M, Rioux JD, Duerr RH, Silverberg MS, Cho JH, Hakonarson H, Zwick ME, McGovern DP, Kugathasan (2017). Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology, 152(1), 206-217.e2.
- Huang C, Haritunians T, Okou DT, Cutler DJ, Zwick ME, Taylor KD, Datta LW, Maranville JC, Liu Z, Ellis S, Chopra P, Alexander JS, Baldassano RN, Cross RK, Dassopoulos T, Dhere TA, Duerr RH, Hanson JS, Hou JK, Hussain SZ, Isaacs KL, Kachelries KE, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kumar A, Kwon JH, Lazarev M, Mannon P, Moulton DE, Osuntokun BO, Patel A, Rioux JD, Rotter JI, Saeed S, Scherl EJ, Silverberg MS, Silverman A, Targan SR, Valentine JF, Wang MH, Simpson CL, Bridges SL, Kimberly RP, Rich SS, Cho JH, Rienzo AD, Kao LWH, McGovern DPB, Brant SR, Kugathasan (2015). Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology, 149(6), 1575-1586.
- Melmed GY, Pandak WM, Casey K, Abraham B, Valentine J, Schwartz D, Awais D, Bassan I, Lichtiger S, Sands B, Hanauer S, Richards R, Oikonomou I, Parekh N, Targan S, Johnson K, Hariri R, Fischkoff (2015). Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. Inflammatory bowel diseases, 21(8), 1809-16.
- Panaccione R, Sandborn WJ, Gordon GL, Lee SD, Safdi A, Sedghi S, Feagan BG, Hanauer S, Reinisch W, Valentine JF, Huang B, Carcereri (2015). Briakinumab for treatment of Crohn's disease: results of a randomized trial. Inflammatory bowel diseases, 21(6), 1329-40.
- Koboziev I, Jones-Hall Y, Valentine JF, Webb CR, Furr KL, Grisham M (2015). Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases. Inflammatory bowel diseases, 21(7), 1652-73.
- Runtsch MC, Hu R, Alexander M, Wallace J, Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X, Smith DP, Ajami NJ, Petrosino JF, Round JL, O'Connell R (2015). MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget, 6(30), 28556-72.
- Xia CQ, Peng R, Chernatynskaya AV, Yuan L, Carter C, Valentine J, Sobel E, Atkinson MA, Clare-Salzler MJ (2014). Increased IFN-¿-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-¿ production. Journal of immunology (Baltimore, Md., 193(3), 1024-34.
- Faubion WA Jr, Fletcher JG, O'Byrne S, Feagan BG, de Villiers WJ, Salzberg B, Plevy S, Proctor DD, Valentine JF, Higgins PD, Harris JM, Diehl L, Wright L, Tew GW, Luca D, Basu K, Keir M (2013). EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging. The American journal of gastroenterology, 108(12), 1891-900.
- Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu M (2013). Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clinical gastroenterology and hepatology, 11(3), 286-92; quiz e24.
- Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant S (2012). Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflammatory bowel diseases, 18(12), 2277-87.
- Ukhanova M, Culpepper T, Baer D, Gordon D, Kanahori S, Valentine J, Neu J, Sun Y, Wang X, Mai (2012). Gut microbiota correlates with energy gain from dietary fiber and appears to be associated with acute and chronic intestinal diseases. Clinical microbiology and infection, 18, 62-66.
- Dassopoulos T, Nguyen GC, Talor MV, Datta LW, Isaacs KL, Lewis JD, Gold MS, Valentine JF, Smoot DT, Harris ML, Oliva-Hemker M, Bayless TM, Burek CL, Brant S (2010). NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans. The American journal of gastroenterology, 105(2), 378-86.
- Davis MK, Valentine JF, Weinstein DA, Polyak (2010). Antibodies to CBir1 are associated with glycogen storage disease type Ib. Journal of pediatric gastroenterology and nutrition, 51(1), 14-8.
- Ahmadi A, Li Q, Muller K, Collins D, Valentine JF, Drane W, Polyak (2010). Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflammatory bowel diseases, 16(6), 974-81.
- Valentine JF, Fedorak RN, Feagan B, Fredlund P, Schmitt R, Ni P, Humphries T (2009). Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study. Gut, 58(10), 1354-62.
- Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert M (2005). Sargramostim for active Crohn's disease. The New England journal of medicine, 352(21), 2193-201.
- Naser SA, Ghobrial G, Romero C, Valentine J (2004). Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet (London, England), 364(9439), 1039-44.
- Valentine J (2001). Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo. American journal of physiology. Gastrointestinal and liver physiology, 281(4), G1044-50.
- Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat M TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response. medRxiv (Preprint) 2024 Feb 6:2024. medRxiv,
Abstract
- Mach A, Glover S, Valentine J (2012). GM-CSF and IL23 Protect the Intestinal Epithelial Barrier from Disruption by IFN Treatment.
- Gaidos JKJ, Sultan S, Dahl W, Valentine J (2010). Vitamin D Deficiency in Inflammatory Bowel Disease. Advances in IBD Annual CCFA Meeting. Ft. Lauderdale, FL.
He is the deeply knowledge & passionate for what he does everyday..
I am so blessed to have dr. Valentine as my gastroenterologist and ,more importantly, as an excellent person who respects people .
An absolute professional. Has it all: Friendliness, understanding, compassion, directness, and the complete knowledge of his craft. I hope to be his patient all the way to his retirement. I don't dread going to see him; he has always made me feel better about my situation.
I am glad I got Dr. Valentine as my doctor. He came highly recommended by my old Doctor.
Excellent physician who is knowledgeable, supportive, and clearly cares about the health of his patients. I trust his expertise completely.
Great Doctor, communication skills are great at explaining details needed!
Dr. Valentine is a sagacious and assiduous professional who has always provided and shared great medical insight and options for me regarding my condition. Additionally, I get the impression he is always continuing to grow his knowledge in the field to provide me (his patient) the best options for treatment with cogent expectations.
Provides exceptional medical care for the IBD patient
He is so knowledgeable and caring, I hope he never retires
He Cares a great deal and will go to any length to help me feel Better and always has!
Dr Valentine has always been very positive to me. He treats me with respect and shares his Knowledge well!
Knowledgeable, thorough, compassionate
He is the most amazingly excellent physician and I have had many very good ones
He's great!
Dr Valentine is always kind and listens to my concerns and answers all of my questions so that I understand my disease and the plan for treatment. He spends time with me and does not make me feel like he is in a rush. He is also very knowledgeable about my disease and my options.
Highly recommend
Doctor Valentine is an exceptional physician. His knowledge, empathy, and compassion for patient health concerns are very much appreciated.
In the years of treatment for my Crohn's Dr Valentine and his staff rank at the top for the care I have received
I really appreciate Dr. Valentine's thoughtfulness and thoroughness in making plans for my care. I've had him for a few years now and will stay with him for as long as I can!
Dr. Valentine, and all of his staff, are so good to me as a friend and as my doctors. I am amazed at the personal attention they give to me even though they are very busy.
Easy to talk to. Very knowledgeable and concerned
Dr Valentine is very kind and respectful. I trust him with my care.
He is very professional he explains everything to you that you need to hear
I have appreciated his medical help since 2018. I am on a wonderful path and able to stay free of flareups. Dr. Valentine and his staff are helpful and accurate with their decisions. Thanks to all.
I am very impressed with Dr. Valentine and his thoroughness in understanding my medical history of 42 years with Crohn's. He is very meticulous in record keeping and helping me understand challenges that have plagued me from the shortened bowel and what to look for.
Dr. Valentine provides exceptional medical care and he is a very caring and compassionate physician.
I've experienced significant improvement under Dr Valentine's care.
Dr Valentine if one of the best doctors I've ever had!
Fantastic and caring doctor
Dr, Valentine is a wonderful doctor and I highly recommend him if you are looking for a Gastroenterologist. He listens to you; he makes sure to explain things clearly and he follows through on his plan. I had a great experience with him.
If anyone has gastro problems like mine, I will recommend Dr, Valentine to them.
I have confidence in Dr Valentine. I feel that he is very knowledgeable, and he doesn't rush when we are in an appointment. He listens for my input and always explains things thoroughly. I feel like I am getting the very best care.
Best doctor I have ever had treating me and my Crohn's
Dr Valentine is wonderful! He saved My life!
Dr. Valentine is fantastic! I have previously been treated by 3 other gastroenterologists . He is the best at listening, checking every aspect of the symptoms throughly and discussing and explaing a plan going forward. I was so impressed when I first started as his patient. I had been told by other gastroenterologists that I would have to stay on medicarion forever. His response was that our goal is to get you to the point you won't need medication. How refreshing!
Already answered this question.
I was very impressed with how thorough Dr Valentine was and the care that I received. I was also impressed with the support offered the incase future complications.
I was heard about my concerns and provided a remedy that was explained clearly
Very positive.
Highly recommended
Excellent doctor. Cares about patients.
An exceptional experience
Ive been dealing with Crohns for over 15 years at this point and he told me things Ive never heard from any other doctor. Eager to try out a new approach, but really havent moved forward with anything yet. Seems promising though!
Great Dr.he really Listen to all my questions give me answers.
Great healthcare provider. Not only does Dr Valentine provide great medical care, he does so with a caring manner.
Dr is so kind and helpful.
He is one of the best doctors I have ever had. He cares very much and he is very thorough.
Very professional and concerned with patients well being.
Dr. Valentine was kind and professional. He took his time to explain things to me and was thorough in answering the questions I had.
I have been with him a long time. I trust him with my issues completely.
Excellent physician. Very detail oriented.
I have had a serious chronic disorder of 50 years duration and have been cared for at the 4 of the finest hospitals in the US. Doctor John Valentine is the absolute best doctor I have ever had.
I have the upmost confidence in Doctor Valentine.
Dr Valentine has been my doctor for almost 10 years and he is very good at what he does. He is on the quiet side, but he is always taking everything in and processing them so he can help you in the best way. I would not trust any other doctor with my care as much as I do him.
He is very patient, kind and helpful. He is an expert in his field of medicine.
Very informative and caring.
My Doctor is the best
Dr. Valentine great to work with.Thanks
Dr. Valentine is a peach, love the guy.
Dr. Valentine is one best doctor I've been in contact with. He is direct and to the point, kind and considerate, friendly and very professional.
Understood my concerns and knew exactly what I was talking about
Loved Dr. Valentine and associates!
Exceptional care
There is never enough time to cover everything. Now my next appointment is in a year except for an emergency or with hands on treatment. He is a very knowledgeable physician and I appreciate his care and expert knowledge. Modern medicine, I guess.
I love Dr Valentine!
DrValentine is super
It is apparent that Dr. Valentine is a thoughtful and caring physician. I appreciated his willingness to answer my questions and make a plan that I was comfortable with.
Dr. Valentine is exceptional. I appreciate his assertiveness.
my meeting was very thorough with full explanations and resources. my comments were listened to and responded to clearly
very satisfied
Dr. Valentine has shared more knowledge and understanding of my condition then any other DR. or specialist has been able to in the last 7 years. I have already been recommending U of U medical to anybody that will listen!
Dr. Valentine is wonderful.
Dr.Valentine is truly professional. but show a high degree of caring in his professional interactions.
Dr. Valentine is is excellent in his approach to my healthcare.
Dr. Valentine had someone he was mentoring talk to me. She asked good questions and was specific abt my situation. Dr. Valentine was in the background but actively participating, coaching her as needed. I had a question abt an over the counter medicine that I had started taking which was related to my condition and asked his advice abt it's efficacy. Dr. Valentine gave his opinion which was very helpful!
Dr. Valentine is amazing. He displays genuine concern for my health and wellbeing.
excellent care
Dr Valentine is excellent -Would highly recommend
It was all well done.
Always very professional
If there is a little bit more explanation about my situation will be perfect.
Dr. Valentine is exceptional. I have been impressed with his care and concern and overall treatment plan progression for my diagnosis.
Have already recommended
good experience
Dr. Valentine is great. He listened to my questions and answered them thoroughly.
I am a physician myself, Dr. Valentine is an ideal physician in all ways
the virtual visit was super easy. I was contacted well ahead of time that it would be virtual
I think he is very professional because he and his assistant asked a lot of questions and he knew every detail he needs to know about me. Literally, he did not show enough concern and give enough explanation, but I understood and appreciated what he has done. I hope every doctor can give patients an overall evaluation after interview and tell them what their current situation are, what they should do after interview, and why the proposed treatments are best for them.
good discussion
Dr. Valentine is a very attentive listener and answers all questions with expertise.
doctor is likeable, knowledgeable and proctive
Dr Valentine is great to work with, & it feels like he is really collaborating with me with an open mind to my concerns.
Dr. Valentine and Julie were both very informative, looked after my needs as a patient, helpful, on time and always helping to do whats best for me. They are always amazing!
Wow! I am super impressed with Dr. Valentine and his staff. Everyone was compassionate and caring. Dr. Valentine was very thorough, as I am a complicated patient. He even called my other specialist to coordinate care while I was in the room. He listened and answered all of my questions. He is the epitome of a great doctor!
Dr. Valentine is a top-notch doctor. I trust him in every aspect of my care with regard to Crohns disease. He is very pleasant to talk to and I am so glad that he is treating me. I have been trying to get my grandson to come in, and he is thinking about it.
Dr. Valentin is a very caring doctor. and I would recommend him for sure.